This is consistent with two reports published recently, where SMYD1 transcript levels were downregulated in cardiac tissue obtained from patients with ischemic or non-ischemic cardiomyopathy undergoing LVAD implantation [65] or from left ventricular tissue samples obtained at the time of heart transplantation [53]. This evidence concerns the gene SMYD1 and ischemic cardiomyopathy.